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Abstract
In this study, the role of CX3CR1 in the progression of diabetic retinopathy (DR) was investigated. 
The retinas of wild type (WT), CX3CR1 null (CX3CR1gfp/gfp, KO) and heterozygous 
(CX3CR1+/gfp, Het) mice were compared in the presence and absence of streptozotocin (STZ) 
induced diabetes. CX3CR1 deficiency in STZ-KO increased vascular pathology at 4 months of 
diabetes, as a significant increase in acellular capillaries was observed only in the STZ-KO group. 
CX3CR1 deficiency and diabetes had similar effects on retinal neurodegeneration measured by an 
increase in DNA fragmentation. Retinal vascular pathology in STZ-KO mice was associated with 
increased numbers of monocyte-derived macrophages in the retina. Furthermore, compared to 
STZ-WT, STZ-KO mice exhibited increased numbers of inflammatory monocytes in the bone 
marrow and impaired homing of monocytes to the spleen. Induction of retinal IL-10 expression by 
diabetes was significantly less in KO mice, and when bone marrow-derived macrophages from KO 
mice were maintained in high glucose they expressed significantly less IL-10 and more TNF-α in 
response to LPS stimulation. These findings support that CX3CR1 deficiency accelerates the 
development of vascular pathology in DR through increased recruitment of proinflammatory 
myeloid cells that demonstrate reduced expression of anti-inflammatory IL-10.
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INTRODUCTION
Diabetic retinopathy (DR) is the leading cause of blindness in working-age adults. During 
the first two decades of the disease, nearly all individuals with type 1 diabetes and 
approximately 60% of individuals with type 2 diabetes will develop some degree of DR [1]. 
It is therefore imperative to understand the progression of the disease from the early to late 
stages. Currently, there are no treatment options for the early phase DR, with interventions 
only becoming available after vision has been compromised [2]. This limits management of 
DR risk to aggressive regulation of hyperglycemia, serum hyperlipidemia and hypertension 
[2].
Microvascular changes remain the clinical hallmark of DR and the current therapeutic target. 
Our understanding of its pathobiology includes inflammation and neurodegeneration in the 
early phase of the disease [3]. In the mouse streptozotocin (STZ) induced type 1 model, 
inflammation is detected within 2–8 weeks of initiation of diabetes, evidenced by activation 
of the endothelium, low-level elevation of pro-inflammatory cytokine expression and 
leukostasis [4]. At the same time, microglia, the endogenous immune cells of CNS and the 
retina, show evidence of activation, with decreased ramification and slightly increased 
expression of pro-inflammatory cytokines [5]. Apoptosis of retinal neurons is also initiated 
during this early stage of DR, leading to accumulative loss of retinal ganglion cells (RGC) 
[3,6–8]. Finally, after approximately 6 months of experimental diabetes, vascular pathology 
is evident in the murine diabetic model [4]. Thus, in the time window between 2 and 6 
months the functions of resident microglia and invading monocytes, including their role in 
clearance of apoptotic cells, may be key determinants of maintaining retinal homeostasis and 
are critical to avoiding a severe inflammatory response. In analogy to other chronic 
neurodegenerative diseases [10,11], it is feasible that a first wave of the inflammatory 
cascade, including the expression of “on” cytokines such as TNFα and IL-1β, is 
counterbalanced by expression anti-inflammatory “off” cytokines such as IL-10 produced 
during clearance of apoptotic cells.
In peripheral tissues CX3CR1 is expressed by innate immune cells [12,13], including, a 
subset of Ly6Clo/CX3CR1hi monocytes that have the unconventional role of maintaining 
vascular endothelial cell homeostasis [14]. They patrol the luminal side of the endothelium, 
scavenge cellular debris, and are believed to occasionally extravagate and differentiate into 
inflammatory macrophages or dendritic cells [14]. These patrolling monocytes are 
associated with resolution of inflammation and are considered anti-inflammatory. In 
contrast, classical pro-inflammatory Ly6Chi/CCR2+ monocytes lack CX3CR1 expression. 
We have consistently shown that diabetes skews hematopoiesis towards a myeloid 
phenotype with an increased infiltration of inflammatory CCR2+ monocytes in the retina 
[15–19].
In the CNS and retina CX3CR1 is expressed by microglial cells [20]. Microglia are the 
endogenous retinal immune cells, distributed throughout the retinal parenchyma, 
continuously surveying their microenvironment with their long processes [5,21]. In response 
to infection or retinal damage they become activated, retract their processes and produce 
damaging neuroinflammatory mediators, including, inflammatory cytokines, nitric oxide and 
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reactive oxygen species that can contribute to killing of neurons [5]. Microglia also maintain 
homeostasis of neural tissue by phagocytosis of apoptotic neurons and cell debris.
Recent studies suggest that the CX3CR1 and its ligand, CX3CL1, play an important role in 
suppression of neuroinflammation and controlling the fate of the neurons. CX3CL1 is 
expressed on the surface neurons in the CNS and endothelial cells in non-neuronal tissues 
[22]. In the mouse retina, CX3CL1 is expressed on ganglion cells and within the inner 
plexiform layer [23]. Activation and downstream effects of the CX3CL1-CX3CR1 signaling 
are complex, tissue-dependent and are likely influenced by many factors. For example, it has 
been implicated in suppression of inflammation in the eye [24–26] and exacerbation of 
macrovascular disease [27,28]. Furthermore, in the CNS, CX3CR1 can exert both 
neuroprotective and neurotoxic effects, depending on the pathological scenario [29]. 
Therefore, this chemokine pathway requires tissue- and disease-specific characterization.
Few publications report on the CX3CL1-CX3CR1 axis in DR. In these, diabetic mice have 
been shown to exhibit increased infiltration of CD11b+ cells with elevated expression of 
CX3CR1 in the retina [30,31]. These studies were done in murine models of diabetes at 
early times points (less than 2 months of diabetes). Additionally, a recent study by Cardona 
and coworkers found that CX3CL1 levels were increased in the retina of diabetic mice [32], 
while CX3CR1 deletion resulted in enhanced activation of microglia and increased loss of 
RGC and their axons. However, the vascular phenotype was not examined. Furthermore, a 
study by McMenamin’s group demonstrated that CX3CR1 deficiency exacerbated diabetes-
associated activation of retinal microglia and accumulation macrophages in the vitreous and 
subretinal space [33].
In the present study, we investigated the effects of CX3CR1 absence on the development of 
DR. We chose 4 months as an endpoint for our studies in order to examine the effects of 
CX3CR1 deficiency in the window of time between inflammation and vascular defects and 
to determine if progression of vascular disease was affected by CX3CR1 deletion. We found 
that CX3CR1 deletion accelerated vascular pathology in the retina, increased retina cell 
apoptotic death with coincident activation of local microglia or infiltration of macrophages. 
We further observed that CX3CR1 deletion in bone marrow derived macrophages reduced 
their IL-10 expression, signifying a role for this cytokine at the critical homeostatic window 
of 4 months diabetes in the experimental STZ murine model.
RESEARCH DESIGN AND METHODS
Animal studies
All mice used in this study were bred in the University of Florida facility and were on the 
C57BL/6J genetic background. CX3CR1gfp/gfp and C57Bl/6J mice were obtained from the 
Jackson Laboratory (Bar Harbor, Maine) CX3CR1gfp/gfp have been backcrossed to the 
C57Bl/6J background for more than 12 generations. CX3CR1+/gfp were generated by 
breeding CX3CR1gfp/gfp with C57BL/6J mice. The experimental groups include: 
CX3CR1gfp/gfp mice, referred to as “KO”; CX3CR1+/+ mice, referred to as “WT”, and 
CX3CR1gfp/+ mice, referred as “Het”. The studies presented included both male and female 
mice. The procedures were carried out in accordance with the guidelines of the University of 
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Florida Institutional Animal Care and Use Committee (IACUC). Type 1 diabetes was 
induced by intraperitoneal injection of STZ (50 mg/kg in 100mM sodium citrate, adjusted to 
pH 4.5) for five consecutive days. Control mice were injected with vehicle (Veh) alone. 
Diabetes was verified two weeks later by measuring blood glucose (defined as >250 mg/dL) 
using a glucose meter (Glucometer Elite XL; Bayer Corp, Elkhart, IN) according to the 
manufacturer’s instructions. Six experimental groups were established: 1) Veh-WT, 2) Veh-
Het, 3) Veh-KO, 4) STZ-WT 5) STZ-Het and 6) STZ-KO. Animals were maintained in a 
hyperglycemic state for 4 months. Glycated hemoglobin was measured at the end of the 
study and animals were considered diabetic if > 7.5%.
Trypsin digest preparation of retinal vasculature
Retinal vasculature was prepared as previously described [34] with minor modifications. 
Briefly, fixed retinas were digested in 3% trypsin (BD Biosciences, San Jose, CA) in 0.1M 
Tris buffer in 2–4 cycles of 30 min digestion at 37°C on a slow shaker and washed in water 
until all only vascular tissue remained. The vasculature was mounted on a clean slide, 
allowed to dry, stained with PAS-H&E (Sigma, St. Louis, MO), dehydrated and mounted in 
Permount mounting media (Sigma). Slides were scanned by Aperio CS slide-scanning 
system with Spectrum Plus information management system (Aperio Technologies, Inc. 
Vista, CA). Ten to 15 random, non-overlapping fields from each retina were imaged. 
Acellular capillaries of >50 μm in length were counted from images for each retina and 
expressed as number of acellular vessels per mm2.
Cell preparation
Retinas, and hypothalamus were shipped overnight to Duke University where single cell 
suspensions were prepared the next day. Spleens, hind legs and blood were processed the 
same day at University of Florida, according previous published methods [15]. Retinas from 
8 mice per group were pooled together in 15 mL tubes and were digested with 2 mg/mL 
Collagenase D (Roche, Indianapolis, IN) at 37°C for 45 min according to O’Koren et al. 
2016 [35]. Cells were washed twice and then stained with antibodies for flow cytometry as 
described in the following sections.
DNA fragmentation assay
Apoptotic DNA cleavage was assayed using an ELISA Kit (Cell Death Detection, Roche 
Applied Science, Indianapolis, IN) and normalized to retinal wet weight following exactly 
the method previously described by Abcouwer et al 2010 [36]. Relative DNA fragmentation 
was expressed as optical density (light absorbance at 405 nm with a 490 nm reference 
wavelength) normalized by retinal mass in each aliquot of retinal supernatant.
Flow cytometry and FACS analysis
Antibodies were purchased from BD Biosciences, San Jose, CA unless otherwise stated. 
Combinations of the following antibodies were used for staining: PerCPCy5.5- CD3e 
(145-2C11); PerCPCy5.5- CD19 (1D3); PerCPCy5.5- NK1.1 (PK136), PerCPCy5.5- Ly6G 
(1A8), APC- CD11c (HL3); APC- or Pacific Blue- F4/80 (BM8); APC- IA-b (AF6-120.1), 
PE- CCR2 (475301); PECy7-Ly6C (Al-21); APC-Cy7- or PE- CD11b (M1/7); PE-CF594- 
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CD45 (30-F11) DAPI; fixable-viability dye efluor780 (ebiosciences). Retinal and brain 
samples were stained with antibodies against F4/80, PECy7, IA/IE, Ly6G, CD11b and 
CD45. Stained samples were acquired immediately after staining on a LSR II flow 
cytometer at the flow cytometry shared facility in University of Florida. Data were analyzed 
using FlowJo software (Tree Star, Ashland, OR, USA).
Bone marrow-derived macrophages (BMDMs)
Macrophages were derived from cultures of bone marrow cells (2×106 cells/mL) in non- 
treated plastic 100 mm plates with 10ng/mL recombinant M-CSF (Sigma-Aldrich, St. Louis, 
MO) in 10% FBS, DMEM (Gibco™) media with antibiotics (Gibco™). Media changes were 
performed at 3.5 days and at day 7. Macrophages were harvested with trypsin-EDTA 
treatment for 15 min at 37°C and seeded in 12 well plates for further polarization. 
Macrophages were stimulated for the next 24 h with or without LPS (10 ng/mL, Sigma) and 
murine IFN-γ (100 ng/mL, Sigma). Glucose was adjusted to 5 mM and 25 mM with the 
addition of 45% glucose solution (Gibco™). At the end of the experiment, cells were lysed 
and RNA was extracted as described in the methods.
RNA isolation and RT-PCR
RNA from BMDM and retina was isolated using the RNeasy Mini Kit (Qiagen, 
Germantown, MA) according to the manufacturer’s instructions. RNA was quantified with a 
Nanodrop 1000 (Thermo Scientific, Whaltman, Massachusetts). Reverse transcription was 
carried out using the Superscript VILO cDNA Synthesis Kit (Life Technologies, Carlsbad, 
California). Real-time PCR was performed on an ABI PRISM 7900HT Sequence Detection 
System, using TaqMan Fast Universal PCR Master Mix (2X) (Life Technologies) and 
TaqMan primer/probe gene expression assays. Relative quantification of gene expression 
was carried out using 18S endogenous control and the ΔΔCt method. All the results were 
expressed relative to the Veh-WT control.
Data analysis
All data were analyzed for outliers prior to treatment comparisons. Comparisons between 
the groups were assessed using a one-way ANOVA followed by the Tukey post-hoc test. A 
p-value <0.05 was considered significant.
RESULTS
Metabolic characteristics of experimental animals
Glycated hemoglobin and post-study body weights are displayed in Table 1. STZ-diabetes 
was associated with elevated glycated hemoglobin and decreased body weight in all groups 
and there was no significant effect of genotype.
Absence of CX3CR1 leads to acceleration of diabetic retinopathy
As expected, there was no significant difference between the number of retinal acellular 
capillaries in the WT, Het or KO animals that were treated with vehicle as all represented the 
corresponding nondiabetic controls. Furthermore, the number of acellular capillaries was not 
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significantly increased in the diabetic WT (STZ-WT) compared to Veh-WT, nor in the STZ-
Het compared to its Veh-Het control, as 4 months of diabetes is considered an early time for 
vascular pathology in WT mice. In contrast, diabetic KO (STZ-KO) mice had significantly 
higher numbers of acellular capillaries compared to vehicle treated KO (Veh-KO) mice 
(Figure 1), indicating acceleration of vascular pathology in the absence of CX3CR1. 
Because the Veh-Het and the STZ-Het responded similarly to the WT controls with regard to 
the primary endpoint of DR (acellular capillaries), we did not study these cohorts further and 
used the WT as the sole control for all subsequent studies.
Absence of CX3CR1 and diabetes increased apoptosis in the retina
The absence of CX3CR1 in the retina led to increased apoptosis as measured by an increase 
in DNA fragmentation in the Veh-KO treated animals. A marked increase was also observed 
due to diabetes in the STZ- WT and STZ- KO mice (Figure 2).
Absence of CX3CR1 leads to increased myeloid cells in the neuronal tissues
We observed slightly higher numbers of Iba-1+ cells in the STZ-KO compared to STZ-WT 
(data not shown). However, Iba-1 does not distinguish between microglia and bone derived 
macrophages. To assess whether the absence of CX3CR1 in diabetes leads to increased 
infiltration of bone marrow-derived myeloid cells, retinas and brains were analyzed by flow 
cytometry. Our gating strategy, which is summarized in the supplemental Fig. 1, separates 
resident microglia (CD45dim cells) from bone marrow derived macrophages (CD45high cells) 
and distinguish bone marrow derived macrophages as Ly6Clo F480hi cells [35]. In the retina 
of WT mice, bone marrow macrophage accumulation was 0.735% in Veh-WT and increased 
to 2.79% in STZ-WT, representing a 4-fold increase of macrophages with diabetes (Figure 
3). In the absence of CX3CR1, diabetes had a greater effect resulting in an increase of 
macrophages from 0.461% in Veh-KO to 4.23% in STZ-KO. This represented a 10-fold 
accumulation of macrophages within the retina. Thus, the absence of CX3CR1 activated 
resident microglia and recruited bone marrow derived immune populations into the retina.
We next examined the brains in these cohorts of mice using the gating strategy described 
above. As shown in Figure 4, there were slightly fewer macrophages in Veh-KO compared 
to Veh-WT (3.75% vs. 5.25% respectively). STZ-KO brains contained 5.75% macrophages 
compared to 8.18% in STZ-WT, indicating that the increased recruitment of bone marrow 
cells was specific to the retina.
Effect of CX3CR1 deletion on monocytes in the peripheral tissues
Monocyte populations from the blood, bone marrow and spleen (representing the major 
sources of circulating monocytes) were identified by flow cytometry using a gating strategy 
described in supplemental Fig. 2. CX3CR1 deficiency had no effect on the relative 
percentages of monocytes in the blood (Figure 5A, left panel); diabetes resulted in increased 
monocytes numbers in the bone marrow and this effect was even higher in the absence of 
CX3CR1 (Figure 5A, center panel). However the STZ-KO mice had significantly reduced 
monocytes in the spleen compared to STZ-KO (Figure 5A, right panel).
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Further characterization of the monocyte subsets revealed that diabetes had higher impact 
than CX3CR1 deletion. Diabetes resulted in increased ratio of inflammatory to patrolling 
monocytes (Ly6Chi to Ly6Clo ratio) in the blood (Figure 6B left panel), and spleen (Figure 
6B right panel) but not in the bone marrow (Figure 6B center panel).
Changes in inflammatory and anti-inflammatory mediators in diabetic retina of KO and WT 
mice
To examine the role of CX3CR1 in the progression of DR, we performed RT-PCR analysis 
of mRNAs for a series of retinal genes: i) expressed by activated endothelium (ICAM-1, 
VCAM-1, VEGF), ii) expressed by inflammatory M1 macrophages (iNOS, CD11c), iii) 
expressed by alternative activated M2 macrophages (IL-10, Arg1); and iv) mediators of 
clearance of apoptotic cells by macrophages (IL-10, TGF-β1, TGF-β2, PTGES, MERTK, 
P2RX7, LXRa, ABCA1, TGM2, RETNL). We also examined retinal mRNA levels of 
chemoattractants (CCL2, CCL5, SDF-1) and inflammatory cytokines (TNF-α, IL-1β, IL-6). 
At 4 months of diabetes we did not observe changes in ICAM-1, VCAM-1, VEGF, TNF-α, 
IL-6 and SDF-1. However, CX3CR1 absence led to increased iNOS mRNA expression with 
diabetes (Figure 6A). The only inflammatory cytokine that remained increased with diabetes 
at 4 months was IL-1β. Levels were higher in STZ -WT compared to Veh-WT, however, 
IL-1β expression was not higher in STZ-KO compared to Veh-KO (Figure 6B). IL-10 was 
the only gene we found to be upregulated during resolution of inflammation and clearance of 
apoptotic cells in the retina of STZ-WT mice. Importantly, IL-10 was significantly reduced 
in the retinas of STZ-KO (Figure 6C). CCL5, a chemokine that attracts monocytes, was also 
increased only in the STZ-WT mice (Figure 6D) but unchanged in the STZ-KO.
Bone marrow-derived macrophages from KO mice produce less IL-10
To examine the effect of CX3CR1 deletion on the function of infiltrated macrophages, we 
obtained bone marrow derived macrophages (BMDMs) and cultured these under high 
glucose conditions in vitro. BMDMs from Veh-WT and Veh-KO mice were derived under 
normal glucose media (5mM) for 7 days and then cultured for another 24 hours in normal 
(5mM) or high (25mM) glucose in the presence or absence of an inflammatory stimulus 
(LPS, 10ng/mL + IFNγ, 100ng/mL). As shown in Figure 7A, BMDMs from KO mice 
stimulated under high glucose conditions produced less anti-inflammatory IL-10 compared 
those in low glucose conditions. Furthermore, when they were stimulated with LPS + IFNγ, 
BMDMs from KO mice in high glucose conditions displayed significantly elevated TNFα 
production (Figure 7B). These data indicate that deletion of CX3CR1 predisposed 
macrophages towards a more inflammatory (higher TNFα) and less anti-inflammatory (less 
IL-10) phenotype.
To verify the inability of macrophages from CX3CR1-KO mice to produce IL-10, we 
generated BMDMs from Veh-WT and Veh-KO in 5mM glucose media and compared them 
to BMDMs from STZ-WT and STZ-KO generated in 25mM glucose media. As shown in 
Figure 7C, the STZ-KO BMDMs expressed significantly reduced IL-10 compared to STZ-
WT BMDMs in response to both LPS + IFNγ (Figure 7C) and IL-4 (Figure 7D). All 
together this data would suggest that CX3CR1 affects macrophage function and IL-10 
expression.
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DISCUSSION
Lack of CX3CR1 accelerated the progression of diabetic retinopathy in mice. At four 
months of diabetes, STZ-WT mice are not expected to display retinal vascular pathology, as 
measured by the formation of acellular capillaries, an assay indicative of retinal 
microvascular damage. Indeed, there was no significant difference between Veh-WT and 
STZ-WT at this time point; however, in the absence of CX3CR1, STZ-KO mice had 
significantly elevated numbers of acellular capillaries at 4 months of diabetes, compared to 
Veh-KO controls. We utilized WT rather than mice that were heterozygous for CX3CR1 in 
our studies. Previously published studies show that no difference existed between Het and 
WT mice regarding surface expression of CX3CR1 [32,37]. Furthermore, other studies have 
made direct comparisons between WT and KO [38–40].
We investigated if at 4 months, apoptosis was increased with diabetes. Loss of CX3CR1 had 
detrimental effects in the retina as, even in the absence of diabetes, deletion of CX3CR1 
increased retinal apoptotic cell death. Since the CX3CR1 KO mice exhibited a high level of 
retinal cell apoptosis, we examined the retina for activated microglia and bone marrow 
derived macrophages, as these cells participate in resolution of inflammation and clearance 
of apoptotic cells. We found that STZ-KO mice had increased numbers of activated 
microglia and increased bone marrow derived macrophages in their retinas compared to the 
other groups. This increase in the homing of macrophages in the STZ-KO mice was 
observed in the retina but not in the brain. Furthermore, CX3CR1 deletion in the presence of 
diabetes caused perturbation of the myeloid population in the bone marrow. To reconcile the 
role of infiltrated macrophages in the retina of STZ-KO mice, we examined a series of genes 
known to be upregulated during inflammation and clearance of apoptotic cells by 
macrophages. At 4 months of diabetes when a high degree of apoptosis was detected, 
proinflammatory “on” cytokines were inhibited, however, in the STZ-KO retina iNOS 
expression was significantly higher.
Among the anti-inflammatory “off” cytokines that are upregulated during clearance of 
apoptotic cells, only IL-10 was significantly increased in the retinas of STZ-WT. However, 
IL-10 expression was not increased in retinas of STZ-KO mice. Furthermore, expression of 
IL-10 was reduced in bone marrow-derived macrophages from the STZ-KO mice generated 
and activated under high glucose conditions. The role of IL-10 in the progression of DR is 
not yet clear. Our research highlights that this anti-inflammatory molecule has important 
repercussions for the health of the retina. Overall, our studies suggest a role for CX3CR1 in 
retinal homeostasis during early stages of diabetes; its absence may compromise the ability 
of microglia and macrophages to promote clearance of apoptotic cells or to suppress 
inflammation following phagocytosis, thus leading to enhanced vascular pathology.
CX3CR1 can exert both neuroprotective and neurotoxic effects in the CNS, depending on 
the pathological scenario. Kezic et al. determined that CX3CR1 deficiency exacerbated the 
diabetes-associated activation of retinal microglia [33]. Loss of CX3CR1 signaling leads to 
failure of microglia homeostatic functions, including phagocytosis, immune surveillance, 
homing and injury response [41,24]. However, in this study the authors did not differentiate 
between microglia and tissue-derived macrophages and they did not relate microglia and 
Beli et al. Page 8
J Mol Med (Berl). Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
recruited macrophage function with neurodegeneration. Finally, other studies have shown 
that even under normal conditions CX3CR1-deficient mice exhibit accumulation of 
subretinal microglia and macrophages [42,43,25]. Importantly, the prolonged presence of 
macrophages and microglia in the subretinal space is associated with retinal degeneration 
[44,42].
A limitation of our study is that we have only used a single time point for the analysis, 4 
months. We do not have data for longer time points wherein the subtle differences we found 
at 4 months may have be more profound at 6 or 9 months. However, at the 4 months 
CX3CR1 deletion led to increased DNA fragmentation in the retinas of Veh-KO mice, even 
in the absence of diabetes. These data suggest that CX3CR1 has an important homeostatic 
role in the retina and disruption of this system potentially predisposes the retina to 
neurodegeneration. A likely explanation for the initiation of apoptosis observed even in Veh-
treated KO mice is the absence of CX3CL1’s neurotrophic effects and the subsequent 
increase of apoptosis of the neuroretina. Our studies expand on this explanation: in the 
presence of diabetes, CX3CR1 deletion compromises the clearance of apoptotic cells from 
the retina. The observed accumulation of myeloid cells in STZ-KO mice likely occurs to 
facilitate the processing of the increased numbers of apoptotic cells. Our data (Figure 6) 
suggests that under high glucose conditions the CX3CR1-deficient macrophages are 
predisposed to adopting a more proinflammatory phenotype and to produce less IL-10. 
Together, these observations emphasize the notion that CX3CR1 is important for 
maintenance of retinal homeostasis both in basal as well as in pathological conditions.
To identify whether these changes are reflected in other peripheral tissues, monocyte 
populations in blood, bone marrow and spleen (major sources of circulating monocytes) 
were identified by flow cytometry. The contribution of bone marrow-derived cells to the 
acceleration of retinopathy is well established [45]. We also have shown that diabetes skews 
hematopoiesis towards the generation of more pro-inflammatory monocytes, fewer anti-
inflammatory monocytes and lower numbers of reparative progenitor cells [15–19]. Bone 
marrow progenitors from diabetic mice generate higher numbers of myeloid colonies, which 
is attributed to increased levels of M-CSF and inflammatory cytokines such as IL-1β, IL-27 
and IFN-γ in the bone marrow microenvironment [17]. These pro inflammatory monocytes 
become trapped within retinal capillaries [30,46] and activate the vasculature [45]. 
Accordingly, we showed that inflammatory CCR2+ monocytes accumulate in the retina of 
STZ diabetic mice, implicating the CCL2-CCR2 axis in the development of DR [17]. Our 
group has also examined the diurnal variation in the levels of inflammatory, Ly6Chi/CCR2+ 
monocytes and found that diabetes not only results in higher circulating levels but also a 
“phase advance” of the diurnal release of these cells into the circulation that coincides with 
an increase in expression of adhesion molecules on the vascular endothelium [17,18]. 
CX3CR1 deletion predisposed the bone marrow of STZ-KO mice to contain more 
monocytes, in particular more inflammatory Ly6Chi monocytes compared to bone marrow of 
STZ-WT mice. This would facilitate the accumulation of more inflammatory and less cells 
resolving inflammation in the diabetic retina.
In summary, our findings are consistent with the hypothesis that CX3CR1 activation 
mediates important protective effects at the eye. We show that these beneficial effects are 
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evident, even in the absence of diabetes, and involve mitigating retinal cell apoptosis and 
modulating macrophage function in response to elevated apoptosis. Furthermore, in the 
presence of an inflammatory microenvironment, such as diabetes, the presence of CX3CR1 
likely delays the onset of diabetic retinal pathology. The absence of CX3CR1 permits the 
deleterious effects of diabetes in the retina to occur in an accelerated manner. It is possible 
that CX3CR1 activation, at least in part, is an important mechanism responsible for delaying 
the onset of DR or slowing the progression of DR.
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Key messages
• CX3CR1 deletion in STZ-diabetic mice accelerated the onset of 
diabetic retinopathy (DR).
• The early onset of DR was associated with increased retinal cell 
apoptosis.
• The early onset of DR was associated with increased recruitment of 
bone marrow-derived macrophages to the retina.
• Bone marrow-derived macrophages from CX3CR1 KO diabetic mice 
expressed more TNF-α and less IL-10.
• The role of IL-10 in protection from progression of DR is highlighted.
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Figure 1. Vascular Pathology in the retina
(A) Representative images of trypsin-digested retinas for acellular capillaries (arrowheads) 
in nondiabetic Veh-WT, Veh-Het and Veh-KO mice and in STZ-WT, STZ-Het and STZ-KO 
mice. (B) Quantification of acellular capillaries in each group. Data are expressed per mm2 
and represent mean ± SEM, n = 6. Asterisks indicate statistically significant difference p 
<0.05, one-way ANOVA. Scale bar = 50μm.
Beli et al. Page 15
J Mol Med (Berl). Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. Apoptosis in the retina
Apoptosis was measured by ELISA, as DNA fragmentation in nondiabetic Veh-WT, Veh-
KO mice and in diabetic STZ-WT, and STZ-KO mice. Data is expressed relative to retinal 
mass. Data represents mean ± SEM. n = 5; one per animal. Asterisks indicate statistically 
significant difference p <0.05, t-test).
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Figure 3. Macrophage infiltration in the retina
Flow cytometry diagrams from n = 8 pooled retinas from Veh-WT, Veh-KO, STZ-WT and 
STZ KO mice. Gating strategy is described in Supplemental Fig. 1. Flow diagrams show: 
[live singlets/Ly6G-/CD45hi/F4/80+/− mononuclear cells.
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Figure 4. Macrophage infiltration in the hypothalamic regions of the brain
Flow cytometry diagrams from n = 8 pooled brains from Veh-WT, Veh-KO, STZ-WT and 
STZ KO mice. Gating strategy is described in Supplemental Fig. 1. Flow diagrams show: 
[live singlets/Ly6G-/CD45hi/F4/80+/-] mononuclear cells.
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Figure 5. Peripheral monocyte homeostasis
(A) Percentages of monocytes in the blood, bone marrow and spleen. (B) Ratio of 
percentages of Ly6Chi/Ly6Clo monocytes in the blood, bone marrow and spleen. Gating 
strategy is described in Supplemental Fig. 2. Flow diagrams show: [CD3e, CD19, NK1.1, 
Ly6G)-/(CD11c, F4/80, IA-b)-/CD11b+] mononuclear cells. Data represent mean ± SEM, n 
= 8–11. Asterisks indicate statistically significant difference p <0.05, one-way ANOVA.
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Figure 6. mRNA expression in the retina
Relative (A) iNOS, (B) IL-1β, (C) IL-10, (D) CCL-5 mRNA expression. Data represent 
mean ± SEM, n = 5–6. Asterisks indicate statistically significant difference p <0.05, one-
way ANOVA.
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Figure 7. Inflammatory and anti-inflammatory mediator production by bone marrow derived 
macrophages (BMDMs)
(A and B): BMDMs from Veh-WT and Veh-KO were derived in 5mM glucose for 8 days 
and then further stimulated with nothing (A) or stimulated with LPS (10 ng/ml) and IFNγ 
(100 ng/ml) (B) for 24 hours in low glucose (5mM) or high glucose (25 mM) media. Total 
RNA was isolated and the relative expression of IL-10 (A) and TNF-α (B) mRNAs was 
quantified by RT-PCR using 18S endogenous control and the ΔΔCt method. (C and D): 
BMDMs from Veh-WT and Veh-KO were derived in 5mM glucose and BMDMs from STZ-
WT and STZ-KO were derived in 25mM glucose for 8 days and then further stimulated with 
LPS (10 ng/ml) and IFNγ (100 ng/ml) (C) or IL-4 (10 ng/ml) (D) for 24 hours in low 
glucose (5mM) or high glucose (25 mM) media. Total RNA was isolated and the relative 
expression of IL-10 (C and D) mRNAs was quantified by RT-PCR using 18S endogenous 
control and the ΔΔCt method. Data represent mean ± SEM, n = 5–6. Asterisks indicate 
statistically significant difference p <0.05, one-way ANOVA.
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